-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on TransMedics Group, Raises Price Target to $130

Benzinga·03/09/2026 12:47:41
Listen to the news
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $115 to $130.